Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Alert Alert Alert sbfm About To Blow Up with News on CMO
CMO,IND,PHASE 1 CLINICAL TRIALS= NOT IN A MILLION YEARS
Watch out sbfm is on fire!!!
Adva-27A Lift Off Is About To Happen!!Hold On Tight
That is correct Sbfm Strait To The Moon
Lol lol lol and i will be in an old folks home
A dream you dream alone is only a dream,a dream you dream together is reality.Yes we can; Barrack Obama president of The United States Of America
Now thats well said,to da moon
In a blink of an eye it will be at 10$
Excellent work. Cmo, Ind, Phase1 clinical trials coming this year???????
Good morning America!! Hip Hip Hoouray Adva-27A Breakthrough
This Is Our Week Sunshine Biopharma
Sbfm got funding from grant and is ready for Cmo,Ind,Phase1 clinical trials... Get ready everybody it will get noisy
We are on the way to making history.Hip Hip Hoouray
Sbfm is warming up and going to get real hot this week
T4 houston signal recieved roger over
T4 houston signal recieved roger over
Sbfm is Atomic!!!!
Its finally here my angel.The moment we have been waiting for
Chu Chu Here comes The biggest discovery in cancer research.
The super surge with a twin turbo!!!!
You better believe it my angel sbfm will Shine
Hip Hip Hooray!!! Here comes The Sunshine
Adva27a is shining Yes We Can
That is a great Idea
I feel a big day ahead of Us.
Where are you my Angel
Get this news on local tv news, newspapers, Cnn instead of always puting brakes on marketing expenses.
There is no buyers!!! News did not travel anywhere like usual!! Sbfm management never learn
The News is Big for Advanomics and Sunshine Biopharma
Its has to with this type of news
The latest map of all the genes involved in a set of tumor cells exposes which mutations drive cancer and how to possibly treat them.
The Human Genome Project provided the first glimpse of the power of genetic maps, and ever since, sequencing the DNA code of not just people but also tissues like tumors has become an invaluable tool in medicine. Laying out the biological code that instructs a fertilized egg to mature into the cells, tissues, organs and body systems that define a human being has led to important discoveries about how we get sick when those directions go awry.
And applying that same technique to cancer cells, experts are exposing some of the critical factors that drive cells to divide out of control to form tumors. In the latest advance, researchers at the National Cancer Institute have sequenced all of the genes in a cancer-cell database that was designed to test promising new drug compounds. With the most complete map of tumor aberrations now available, they can determine whether some of the failed drug candidates discarded over the years — there are thousands of them — may actually be useful in treating certain cancers.
(MORE: Decoding Cancer: Scientists Release 520 Tumor Genomes From Pediatric Patients)
“There is an unlimited amount of matching anyone could do,” says Dr. Yves Pommier, chief of the Laboratory of Molecular Pharmacology at the National Cancer Institute and lead investigator of the study, which was published in the journal Cancer Research. “As we integrate this data into the current process of molecular medicine, I think more links [to new drugs] will be made.”
Sequencing the DNA of tumors, and exposing their mutations, is a potent technique for understanding what fuels tumors to develop in the first place, as well as what keeps them going. But until recently, the cost and technology required to sequence all 20,000 or so genes in each of these cancer cells weren’t feasible. The process, says Pommier, “is easy to say, much harder to do,” and it took his team more than two and a half years to complete the maps for the 60 tumor-cell lines, representing nine different cancers, from breast, prostate, brain, lung, colon and kidney tumors. Mapping each of the genes from these cell lines tallied up 6 billion data points that Pommier’s team sequenced, aligned, curated and compared with normal cell genomes in order to come up with the most exhaustive dossier of all the mutations in a specific cancer-cell type to date.
Why cant sbfm hit 2.00 fm radio station with dj tiesto on the turn Table
Hip Hip Hooray Sunshine Biopharma.
This is a big stamp of approval for Adva-27a," said Dr. Steve N. Slilaty, CEO of Sunshine Biopharma. "Our clinical trials are rapidly approaching and we could not be happier that such distinguished and experienced agencies are impressed by our compound. We are extremely grateful for the dedication and support of NSERC, NanoQuebec and Ecole Polytechnique which dovetails with our goal to develop new therapeutics for cancer."
OMG,OMG HISTORY IN THE MAKING
Adva-27a out of fuel!!
Show your Power adva-27a
We all cant wait to see him. He is really smart over the phone. Want to see if he is so smart in person.